Transdermal pain therapy - Matrifen® from Nycomed

Matrifen® is a transdermal pain therapy patch indicated for patients with severe chronic pain such as cancer pain or low back pain.

Transdermal pain therapy in the form of a fentanyl patch relieves pain in patients with prolonged or chronic severe pain.

>> Information on transdermal pain therapy

Matrifen® is a transdermal pain therapy patch indicated for patients with severe chronic pain such as cancer pain, low back pain, naturopathic pain, nociceptive pain and other types of chronic distressing pain. 

Matrifen®’s unique and advanced matrix technology provides 3 day pain relief equal to that of other matrix fentanyl patches, but with a lower drug load adding to a high degree of safety and low environmental burden.

About Nycomed
Nycomed is a pharmaceutical company dedicated to meeting needs in Europe. The company provides hospital products throughout the region and general practitioner and pharmacy medicines in selected markets.

New products are sourced through licensing agreements with research companies. Here Nycomed provides late-stage clinical development, registration and marketing. Nycomed employs about 3,500 people throughout Europe and Russia-CIS.

Breakthrough pain | Treatment of pain | Fentanyl patch therapy